Assay variation confounds the diagnosis of hypovitaminosis D: A call for standardization

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 7, 2004, Pages 3152-3157

  Binkley, N ^a,b   Krueger, D ^a   Cowgill, C S ^a   Plum, L ^a   Lake, E ^a   Hansen, K E ^a   DeLuca, H F ^a   Drezner, M K ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D;

ADULT; AGED; ARTICLE; FEMALE; HUMAN; LABORATORY; MAJOR CLINICAL STUDY; MEASUREMENT; POSTMENOPAUSE; PRIORITY JOURNAL; SERUM; SPIKE WAVE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

AGED; AGED, 80 AND OVER; FEMALE; HEMATOLOGIC TESTS; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; MIDDLE AGED; OSMOLAR CONCENTRATION; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 3242739941     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-031979     Document Type: Article

References (49)

1. Kudlacek S, Schneider B, Peterlik M, Leb G, Klaushofer K, Weber K, Woloszczuk W, Willvonseder R; Austrian Study Group on Normative Values of Bone Metabolism 2003 Assessment of vitamin D and calcium status in healthy adult Austrians. Eur J Clin Invest 33:323-331
2. Gomez-Alonso C, Naves-Diaz ML, Fernandez-Martin JL, Diaz-Lopez JB, Fernandez-Coto MT, Cannata-Andia JB 2003 Vitamin D status and secondary hyperparathyroidism: the importance of 25-hydroxyvitamin D cut-off levels. Kidney Int 63(Suppl 85):S44-S48
3. McKenna MJ, Freaney R 1998 Secondary hyperparathyroidism in the elderly: means to defining hypovitaminosis D. Osteoporos Int 8(Suppl 2):S3-S6
4. LeBoff MS, Kohlmeier L, Hurwitz S, Franklin J, Wright J, Glowacki J 1999 Occult vitamin D deficiency in postmenopausal US women with acute hip fracture. JAMA 281:1505-1511
5. Parfitt AM 1990 Osteomalacia and related disorders. In: Avioli LV, Krane SM, eds. Metabolic bone disease and clinically related disorders. 2nd ed. Philadelphia: W. B. Saunders Co.; 329-396
6. Bischoff HA, Stahelin HB, Dick W, Akos R, Knecht M, Salis C, Nebiker M, Theiler R, Pfeifer M, Bergerow B, Lew RA, Conzelmann M 2003 Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res 18:343-351
7. Trivedi DP, Doll R, Khaw KT 2003 Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 326:469-474
8. Chapuy MC, Pamphile R, Paris E, Kempf C, Schlichting M, Arnaud S, Garnero P, Meunier PJ 2002 Combined calcium and vitamin D3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II Study. Osteoporos Int 13:257-264
9. Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S, Delmas PD, Meunier PJ 1992 Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 327:1637-1642
10. Zittermann A 2003 Vitamin D in preventive medicine: are we ignoring the evidence? Br J Nutr 89:552-572
11. Holick MF 2003 Vitamin D: a millennium perspective. J Cell Biochem 88:296-307
12. Heaney RP 2000 Vitamin D: how much do we need, and how much is too much? Osteoporos Int 11:553-555
13. Chapuy MC, Preziosi P, Maamer M, Arnaud S, Galan P, Hercberg S, Meunier PJ 1997 Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 7:439-443
14. Vieth R 2000 Problems with direct 25-hydroxyvitamin D assays, and the target amount of vitamin D nutrition desirable for patients with osteoporosis. Osteoporos Int 11:635-636
15. Lips P, Chapuy MC, Dawson-Hughes B, Pols HAP, Holick MF 1999 An international comparison of serum 25-hydroxyvitamin D measurements. Osteoporos Int 9:394-397
16. 125I-based RIA methods for the determination of circulating 25-hydroxyvitamin D. Clin Chem 46:1657-1661
17. Glendenning P, Noble JM, Tarante M, Musk AA, McGuiness M, Goldswain PR, Fraser WD, Vasikaran SD 2003 Issues of methodology, standardization and metabolite recognition for 25-hydroxyvitamin D when comparing the DiaSorin radioimmunoassay and the Nichols Advantage automated chemiluminescence protein-binding assay in hip fracture cases. Ann Clin Biochem 40:546-551
18. Jongen MJM, van der Vijgh WJF, van Beresteyn ECH, van den Berg H, Bosch R, Hoogenboezem T, Visser TJ, Netelenbos JC 1982 Interlaboratory variation of vitamin D1 metabolite measurements. J Clin Chem Clin Biochem 20:753-756
19. Jongen MJM, Van Ginkel FCV, van der Vijgh WJF, Kuiper S, Netelenbos JC, Lips P 1984 An international comparison of vitamin D metabolite measurements. Clin Chem 30:399-403
20. Thomas MK, Lloyd-Jones DM, Thadhani RI, Shaw AC, Deraska DJ, Kitch BT, Vamvakas EC, Dick IM, Prince RL, Finkelstein JS 1998 Hypovitaminosis D in medical inpatients. N Engl J Med 338:777-783
21. Lamberg-Allardt CJE, Outila TA, Karkkainen MUM, Rita HJ, Valsta LM 2001 Vitamin D deficiency and bone health in healthy adults in Finland: could this be a concern in other parts of Europe? J Bone Miner Res 16:2066-2073
22. Vieth R, Cole DE, Hawker GA, Trang HM, Rubin LA 2001 Wintertime vitamin D insufficiency is common in young Canadian women, and their vitamin D intake does not prevent it. Eur J Clin Nutr 55:1091-1097
23. Rucker D, Allan JA, Fick GH, Hanley DA 2002 Vitamin D insufficiency in a population of healthy western Canadians. CMAJ 166:1517-1524
24. Looker AC, Dawson-Hughes B, Calvo MS, Gunter EW, Sahyoun NR 2002 Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone 30:771-777
25. Lips P 1996 Vitamin D deficiency and osteoporosis: the role of vitamin D deficiency and treatment with vitamin D and analogues in the prevention of osteoporosis-related fractures. Eur J Clin Invest 26:436-442
26. Ooms ME, Roos JC, Bezemer PD, van der Vijgh WJF, Bouter LM, Lips P 1995 Prevention of bone loss by vitamin D supplementation in elderly women: a randomized double-blind trial. J Clin Endocrinol Metab 80:1052-1058
27. Peacock M, Liu G, Carey M, McClintock R, Ambrosius W, Hui S, Johnston CC 2000 Effect of calcium or 25OH vitamin D3 dietary supplementation on bone loss at the hip in men and women over the age of 60. J Clin Endocrinol Metab 85:3011-3019
28. Heaney RP, Dowell MS, Hale CA, Bendich A 2003 Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr 22:142-146
29. Hypponen E, Laara E, Reunanen A, Jarvelin MR, Virtanen SM 2001 Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 358:1500-1503
30. Zittermann A, Schleithoff SS, Tenderich G, Berthold HK, Korfer R, Stehle P 2003 Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? J Am Coll Cardiol 41:105-112
31. Guyton KZ, Kensler TW, Posner GH 2003 Vitamin D and vitamin D analogs as cancer chemopreventive agents. Nutr Rev 61:227-238
32. Eriksen EF, Glerup H 2002 Vitamin D deficiency and aging: implications for general health and osteoporosis. Biogerontology 3:73-77
33. Roth HJ, Zahn I, Alkier R, Schmidt H 2001 Validation of the first automated chemiluminescence protein-binding assay for the detection of 25-hydroxycalciferol. Clin Lab 47:357-365
34. Haddad JG, Chyu KJ 1971 Competitive protein-binding radioassay for 25-hydroxycholecalciferol. J Clin Endocrinol Metab 33:992-995
35. Skinner RK, Wills MR 1977 Serum 25-hydroxyvitamin D assay. Evaluation of chromatographic and non-chromatographic procedures. Clin Chim Acta 80:543-554
36. Belsey RE, DeLuca HF, Potts Jr JT 1974 A rapid assay for 25-OH-vitamin D3 without preparative chromatography. J Clin Endocrinol Metab 38:1046-1051
37. Bouillon R, Van Herck E, Jans I, Tan BK, Van Baelen H, De Moor P 1984 Two direct (nonchromatographic) assays for 25-hydroxyvitamin D. Clin Chem 30: 1731-1736
38. Souberbielle JC, Lawson-Body E, Kindermans C 2002 Authors' response: vitamin D status and redefining serum PTH reference range in the elderly. J Clin Endocrinol Metab 87:946-947 (Letter)
39. Dorantes LM, Arnaud SB, Arnaud CD 1978 Importance of the isolation of 25-hydroxyvitamin D before assay. J Lab Clin Med 91:791-796
40. Schmidt-Gayk H, Armbruster FP, Bouillon R 1990 Calcium regulating hormones, vitamin D metabolites, and cyclic AMP. Assays and their clinical application. Berlin, Heidelberg, New York: Springer
41. Hollis BW, Napoli JL 1985 Improved radioimmunoassay for vitamin D and its use in assessing vitamin D status. Clin Chem 31:1815-1819
42. Horst RL, Littledike ET, Riley JL, Napoli JL 1981 Quantitation of vitamin D and its metabolites and their plasma concentrations in five species of animals. Anal Biochem 116:189-203
43. 125I-labeled tracer. Clin Chem 39:529-533
44. Lindback B, Berlin T, Bjorkhem I 1987 Three commercial kits and one liquid-chromatographic method evaluated for determining 25-hydroxyvitamin D3 in serum. Clin Chem 33:1226-1227
45. Gilbertson TJ, Stryd RP 1977 High-performance liquid chromatographic assay for 25-hydroxyvitamin D3 in serum. Clin Chem 23:1700-1704
46. Jones G 1978 Assays of vitamins D2 and D3, and 25-hydroxyvitamins D2 and D3 in human plasma by high-performance liquid chromatography. Clin Chem 24:287-298
47. Turpeinen U, Hohenthal U, Stenman UH 2003 Determination of 25-hydroxyvitamin D in serum by HPLC and immunoassay. Clin Chem 49:1521-1524
48. Stenman UH 2001 Immunoassay standardization: is it possible, who is responsible, who is capable? Clin Chem 47:815-820
49. Raiten DJ, Picciano MF, Vitamin D and health in the 21st century: bone and beyond. National Institutes of Health Conference, Bethesda, MD, 2003